Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan

Qian Fan, Wei Zhang, Bo Li, De-Jia Li, Jian Zhang, Fang Zhao, Qian Fan, Wei Zhang, Bo Li, De-Jia Li, Jian Zhang, Fang Zhao

Abstract

Background: The ABO blood group system has been associated with multiple infectious diseases, including hepatitis B, dengue haemorrhagic fever and so on. Coronavirus disease 2019 (COVID-19) is a new respiratory infectious disease and the relationship between COVID-19 and ABO blood group system needs to be explored urgently. Methods: A hospital-based case-control study was conducted at Zhongnan Hospital of Wuhan University from 1 January 2020 to 5 March 2020. A total of 105 COVID-19 cases and 103 controls were included. The blood group frequency was tested with the chi-square statistic, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated between cases and controls. In addition, according to gender, the studied population was divided into two subgroups, and we assessed the association between cases and controls by gender. Finally, considering lymphopenia as a feature of COVID-19, the relationship between the ABO blood group and the lymphocyte count was determined in case samples. Results: The frequencies of blood types A, B, AB, and O were 42.8, 26.7, 8.57, and 21.9%, respectively, in the case group. Association analysis between the ABO blood group and COVID-19 indicated that there was a statistically significant difference for blood type A (P = 0.04, OR = 1.33, 95% CI = 1.02-1.73) but not for blood types B, AB or O (P = 0.48, OR = 0.90, 95% CI = 0.66-1.23; P = 0.61, OR = 0.88, 95% CI = 0.53-1.46; and P = 0.23, OR = 0.82, 95% CI = 0.58-1.15, respectively). An analysis stratified by gender revealed that the association was highly significant between blood type A in the female subgroup (P = 0.02, OR = 1.56, 95% CI = 1.08-2.27) but not in the male subgroup (P = 0.51, OR = 1.14, 95% CI = 0.78-1.67). The average level of lymphocyte count was the lowest with blood type A in patients, however, compared with other blood types, there was still no significant statistical difference. Conclusions: Our findings provide epidemiological evidence that females with blood type A are susceptible to COVID-19. However, these research results need to be validated in future studies.

Keywords: ABO blood group system; COVID-19; association analysis; female; lymphocyte count.

Copyright © 2020 Fan, Zhang, Li, Li, Zhang and Zhao.

Figures

Figure 1
Figure 1
ABO blood type and lymphocyte count level analysis in the case group. (A) Comparisons among every pair of the four blood types via ANOVA. (B) Association analysis between the lymphocyte count and ABO blood type in a linear regression model.

References

    1. Behal R., Jain R., Behal K. K., Dhole T. N. (2010). Variation in the host ABO blood group may be associated with susceptibility to hepatitis C virus infection. Epidemiol. Infect. 138, 1096–1099. 10.1017/S0950268809991117
    1. Cao Y., Li L., Feng Z., Wan S., Huang P., Sun X., et al. . (2020). Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 6:11. 10.1038/s41421-020-0147-1
    1. Chakrani Z., Robinson K., Taye B. (2018). Association between ABO blood groups and Helicobacter pylori infection: a meta-analysis. Sci. Rep. 8:17604. 10.1038/s41598-018-36006-x
    1. Chan J. F., Yuan S., Kok K. H., To K. K., Chu H., Yang J., et al. . (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523. 10.1016/S0140-6736(20)30154-9
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. . (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513. 10.1016/S0140-6736(20)30211-7
    1. Chen Z., Yang S. H., Xu H., Li J. J. (2016). ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Sci. Rep. 6:23250. 10.1038/srep23250
    1. Cheng Y., Cheng G., Chui C. H., Lau F. Y., Chan P. K., Ng M. H., et al. . (2005). ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 293, 1450–1451. 10.1001/jama.293.12.1450-c
    1. Cooling L. (2015). Blood Groups in Infection and Host Susceptibility. Clin. Microbiol. Rev. 28, 801–870. 10.1128/CMR.00109-14
    1. Degarege A., Medhin G., Animut A., Legess M., Erko B. (2012). Association of ABO blood group and P. falciparum malaria related outcomes: a cross-sectional study in Ethiopia. Acta Trop. 123, 164–169. 10.1016/j.actatropica.2012.04.012
    1. Elnady H. G., Abdel S. O., Saleh M. T., Sherif L. S., Abdalmoneam N., Kholoussi N. M., et al. (2017). ABO blood grouping in Egyptian children with rotavirus gastroenteritis. Prz. Gastroenterol. 12, 175–180. 10.5114/pg.2017.70469
    1. Ewald D. R., Sumner S. (2018). Human microbiota, blood group antigens, and disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 10:e1413. 10.1002/wsbm.1413
    1. Gerard C., Maggipinto G., Minon J. M. (2020). COVID-19 and ABO blood group: another viewpoint. Br. J. Haematol. 10.1111/bjh.16884. [Epub ahead of print].
    1. Groot H. E., Villegas S. L., Said M. A., Lipsic E., Karper J. C., van der Harst P. (2020). Genetically determined ABO blood group and its associations with health and disease. Arteriosc. Thromb. Vasc. Biol. 40, 830–838. 10.1161/ATVBAHA.119.313658
    1. Guillon P., Clement M., Sebille V., Rivain J. G., Chou C. F., Ruvoen-Clouet N., et al. . (2008). Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 18, 1085–1093. 10.1093/glycob/cwn093
    1. Heggelund J. E., Varrot A., Imberty A., Krengel U. (2017). Histo-blood group antigens as mediators of infections. Curr. Opin. Struct. Biol. 44, 190–200. 10.1016/j.sbi.2017.04.001
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. . (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506. 10.1016/S0140-6736(20)30183-5
    1. Jing W., Zhao S., Liu J., Liu M. (2020). ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ Open 10:e034114. 10.1136/bmjopen-2019-034114
    1. Kazi A. M., Cortese M. M., Yu Y., Lopman B., Morrow A. L., Fleming J. A., et al. . (2017). Secretor and salivary ABO blood group antigen status predict rotavirus vaccine take in infants. J. Infect. Dis. 215, 786–789. 10.1093/infdis/jix028
    1. Li J., Wang X., Chen J., Cai Y., Deng A., Yang M. (2020). Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br. J. Haematol. 190, 24–27. 10.1111/bjh.16797
    1. Li W., Wong S. K., Li F., Kuhn J. H., Huang I. C., Choe H., et al. . (2006). Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J. Virol. 80, 4211–4219. 10.1128/JVI.80.9.4211-4219.2006
    1. Liao Y., Xue L., Gao J., Wu A., Kou X. (2020). ABO blood group-associated susceptibility to norovirus infection: a systematic review and meta-analysis. Infect. Genet. Evol. 81:104245. 10.1016/j.meegid.2020.104245
    1. Liu J., Zhang S., Liu M., Wang Q., Shen H., Zhang Y. (2018). Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population-based cross-sectional study. J. Viral. Hepat. 25, 401–411. 10.1111/jvh.12829
    1. Liumbruno G. M., Franchini M. (2013). Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus. 11, 491–499. 10.2450/2013.0152-13
    1. Melzer D., Perry J. R., Hernandez D., Corsi A. M., Stevens K., Rafferty I., et al. . (2008). A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet. 4:e1000072. 10.1371/journal.pgen.1000072
    1. Mohammadali F., Pourfathollah A. (2014). Association of ABO and Rh blood groups to blood-borne infections among blood donors in Tehran-Iran. Iran. J. Public Health 43, 981–989.
    1. Murugananthan K., Subramaniyam S., Kumanan T., Owens L., Ketheesan N., Noordeen F. (2018). Blood group AB is associated with severe forms of dengue virus infection. Virusdisease 29, 103–105. 10.1007/s13337-018-0426-8
    1. Neil S. J., McKnight A., Gustafsson K., Weiss R. A. (2005). HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. Blood 105, 4693–4699. 10.1182/blood-2004-11-4267
    1. Singh B. K., Leuthold M. M., Hansman G. S. (2016). tructural Constraints on Human Norovirus Binding to Histo-Blood Group Antigens. mSphere 1:e00049–16. 10.1128/mSphere.00049-16
    1. Storry J. R., Olsson M. L. (2009). The ABO blood group system revisited: a review and update. Immunohematology 25, 48–59.
    1. Tian X., Li C., Huang A., Xia S., Lu S., Shi Z., et al. . (2020). Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg. Microbes Infect. 9, 382–385. 10.1080/22221751.2020.1729069
    1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. . (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 323, 1061–1069. 10.1001/jama.2020.1585
    1. Wiggins K. L., Smith N. L., Glazer N. L., Rosendaal F. R., Heckbert S. R., Psaty B. M., et al. . (2009). ABO genotype and risk of thrombotic events and hemorrhagic stroke. J. Thromb. Haemost. 7, 263–269. 10.1111/j.1538-7836.2008.03243.x
    1. Wolpin B. M., Kraft P., Gross M., Helzlsouer K., Bueno-de-Mesquita H. B., Steplowski E., et al. . (2010). Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 70, 1015–1023. 10.1158/0008-5472.CAN-09-2993
    1. Wrapp D., Wang N., Corbett K. S., Goldsmith J. A., Hsieh C. L., Abiona O., et al. . (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263. 10.1126/science.abb2507
    1. Wu Y. (2020). Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury. Virol Sin. 35, 256–258. 10.1007/s12250-020-00205-6
    1. Wu Z., McGoogan J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 323, 1239–1242. 10.1001/jama.2020.2648
    1. Xiong Q., Xu M., Zhang J., Ji M., An P., Lei H., et al. (2020). Women may play a more important role in the transmission of the Corona virus disease (COVID-19) than men. MedRxiv [Preprint].
    1. Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., et al. . (2020). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12:8. 10.1038/s41368-020-0074-x
    1. Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., et al. . (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420–422. 10.1016/S2213-2600(20)30076-X
    1. Zhao J., Yang Y., Huang H., Li D., Gu D., Lu X., et al. (2020). Relationship between the ABO blood group and the COVID-19 susceptibility. MedRxiv. 10.1101/2020.03.11.20031096. [Epub ahead of print].

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe